最後更新 2024-05-14 07:27:28 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

7.2%


截至2024-03-31

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

Bio-Techne Corporation及其子公司在全球研究和臨床診斷市場上開發、製造和銷售生命科學試劑、儀器和服務。該公司通過兩個部門運營,即蛋白質科學部門和診斷和基因組學部門。蛋白質科學部門開發和製造用於生命科學研究、診斷和細胞和基因治療的生物試劑,如細胞激素和生長因子、抗體、小分子、組織培養血清和細胞選擇技術。該部門還提供蛋白質分析工具,用於自動化的西方墨點法和多重ELISA工作流程,包括手動和自動化的蛋白質分析儀器和免疫分析試劑,用於定量測定各種生物液體中的蛋白質。診斷和基因組學部門開發和製造診斷產品,包括控制品、校準品和用於受管制診斷市場的診斷試劑,基於外泌體的分子診斷試劑,用於空間基因組和組織活檢分析的先進組織內原位雜交試劑,以及用於研究和臨床應用的遺傳學和腫瘤學試劑盒;並銷售用於遺傳載體篩查、腫瘤學診斷、分子控制和研究的產品,以及用於血液學、血液化學和氣體的儀器和過程控制產品,以及用於各種診斷應用的凝血控制品和試劑。它以R&D Systems、Tocris Biosciences、Novus Biologicals、ProteinSimple、Advanced Cell Diagnostics、Exosome Diagnostics和Asuragen品牌提供其產品。該公司以前被稱為Techne Corporation,並於2014年11月改名為Bio-Techne Corporation。Bio-Techne Corporation成立於1976年,總部位於明尼蘇達州明尼阿波利斯市。

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

所屬產業

所屬類股
Healthcare
所屬產業
Biotechnology

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning